Sign Out
Pregnancy: There is no indication for the use of Ovidrel during pregnancy. Data on a limited number of exposed pregnancies indicate no increased risks of malformation or foeto/neonatal toxicity. No reproduction studies with choriogonadotropin alfa in animals were performed (see Pharmacology: Toxicology: Preclinical safety data under Actions). The potential risk for humans is unknown.
Breast-feeding: Ovidrel is not indicated during breastfeeding. There are no data on the excretion of choriogonadotropin alfa in milk.
Fertility: Ovidrel is indicated for use in infertility (see Indications/Uses).
Continue with Google